These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Systemic lupus erythematosus and anti-native desoxyribonucleic acid antibodies: clinical and laboratory comparison of the results given by two methods of detection (author's transl)]. Osnos MC; Eyquem A Nouv Presse Med; 1979 Jul; 8(30):2451-6. PubMed ID: 386262 [TBL] [Abstract][Full Text] [Related]
29. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA. Weill BJ; Renoux ML Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851 [TBL] [Abstract][Full Text] [Related]
30. Identification of three major target molecules of IgM antilymphocyte autoantibodies in systemic lupus erythematosus. Minota S; Winfield JB J Immunol; 1987 Dec; 139(11):3644-51. PubMed ID: 3500225 [TBL] [Abstract][Full Text] [Related]
31. Purification of antilymphocyte antibody (ALA) from patients with systemic lupus erythematosus (SLE)-immunoabsorption and elution. Yamana S; Nakamura Z; Saito Y; Yamamoto M; Ofuji T Acta Med Okayama; 1979 Aug; 33(4):259-67. PubMed ID: 91309 [TBL] [Abstract][Full Text] [Related]
32. Accessory cell activity of monocytes in anti-DNA antibody production in systemic lupus erythematosus. Sasaki T; Shibata S; Hirabayashi Y; Sekiguchi Y; Yoshinaga K Clin Exp Immunol; 1989 Jul; 77(1):37-42. PubMed ID: 2788540 [TBL] [Abstract][Full Text] [Related]
34. Immunofluorescence studies of anti-T cell antibodies and T cells in systemic lupus erythematosus. Selective loss of brightly staining T cells in active disease. Steinberg AD; Klassen LW; Budman DR; Williams GW Arthritis Rheum; 1979 Feb; 22(2):114-22. PubMed ID: 84675 [TBL] [Abstract][Full Text] [Related]
35. Lymphocytotoxic antibodies in mexican patients with systemic lupus erythematosus and their families relationship of disease activity in the probands to antibody cytotoxicity in their relatives. DeHoratius RJ; Alarcón-Segovia D; Messner RP; Fishbein E Rev Invest Clin; 1981; 33(2):161-4. PubMed ID: 7291760 [No Abstract] [Full Text] [Related]
36. [Lymphoreceptopathy in the patients with systemic lupus erythematosus (author's transl)]. Arimori S Nihon Naika Gakkai Zasshi; 1980 Dec; 69(12):1584-9. PubMed ID: 7229477 [No Abstract] [Full Text] [Related]
37. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus? Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929 [TBL] [Abstract][Full Text] [Related]
38. [Effect on lymphocytes from systemic lupus erythematosus patients on DNA synthesis in human bone marrow cells (author's transl)]. Wakabayashi Y; Shiokawa Y; Takaku F Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):493-8. PubMed ID: 696192 [No Abstract] [Full Text] [Related]
39. [Cold-reactive lymphocytotoxin in sarcoidosis--comparison with lymphocytotoxin in sarcoidosis and systemic lupus erythematodes]. Ikeda S; Ando M; Araki S Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Feb; 24(2):130-9. PubMed ID: 3488458 [No Abstract] [Full Text] [Related]
40. [An autopsy case of thrombotic thrombocytopenic purpura (TTP) complicated with systemic lupus erythematosus (SLE)--demonstration of anti-platelet antibody (author's transl)]. Tada T; Kishimoto H Rinsho Ketsueki; 1980 Nov; 21(11):1773-80. PubMed ID: 7193750 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]